Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01430624 · ClinicalTrials.gov registry record · Phase 1
Prevention of Post Sexual Assault Stress
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 245
- Enrollment target
NCT01430624: Completed Phase 1 study, sponsored by Medical University of South Carolina.
NCT01430624 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 245 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (308% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01430624, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 245 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether a brief intervention in video format, that includes education about reactions to assault and modeling of adaptive coping strategies, designed to reduce post assault drug use or abuse and PTSD and shown to recent victims of sexual assault at the time of receipt of post assault medical care is associated with better post-assault outcomes as compared to a comparable length video that includes pleasant imagery and relaxation instruction or standard care.
Primary Outcome
total possible scores range from 0 - 10 with higher scores indicating poor functioning, post assault at 6 months
Interventions
- BEHAVIORAL PPRS
- BEHAVIORAL PIRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2009-05 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
What the finished NCT01430624 record still lists
NCT01430624 is an interventional study that assigns participants to a tested intervention. The registered 245 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (308% higher).
The record links to 0 conditions, and to 2 interventions - of which PPRS is the first listed.
NCT01430624 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01430624 about?
NCT01430624 is a clinical study titled "Prevention of Post Sexual Assault Stress". The purpose of this study is to evaluate whether a brief intervention in video format, that includes education about reactions to assault and modeling of adaptive coping strategies, designed to reduce post assault drug use or abuse and PTSD and shown to recent victims of sexual assault at the time o...
What is the current status of trial NCT01430624?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 245 participants. The study started on 2009-05. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01430624?
The interventions under investigation include: PPRS (BEHAVIORAL), PIRI (BEHAVIORAL).
Who is sponsoring clinical trial NCT01430624?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01430624's enrollment target sits among peer trials
245 189th of 2000 higher than 1,810 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03645928 · 245 participants · Phase 2
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
- NCT04718168 · 245 participants · NA
GORE® ENFORM Biomaterial Product Study
- NCT05145127 · 245 participants · Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- NCT05446259 · 245 participants
Degenerative Cervical Myelopathy Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia